Century Therapeutics Valuation
| IPSC Stock | USD 0.56 0.01 1.82% |
Century Therapeutics is fairly valued. Century Therapeutics shows a prevailing Real Value of $0.54 per share. The current price of the firm is $0.56. Our model approximates the value of Century Therapeutics from analyzing the firm fundamentals such as Operating Margin of (8.22) %, return on equity of -0.73, and Shares Outstanding of 86.05 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Century Therapeutics' valuation include:
Price Book 0.2959 | Enterprise Value | Enterprise Value Ebitda 0.0752 | Price Sales 7.2477 | Enterprise Value Revenue 1.9555 |
Fairly Valued
Today
Please note that Century Therapeutics' price fluctuation is abnormally volatile at this time. Calculation of the real value of Century Therapeutics is based on 3 months time horizon. Increasing Century Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Century Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Century Stock. However, Century Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.56 | Real 0.54 | Target 8.33 | Hype 0.56 | Naive 0.58 |
The real value of Century Stock, also known as its intrinsic value, is the underlying worth of Century Therapeutics Company, which is reflected in its stock price. It is based on Century Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Century Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Century Therapeutics helps investors to forecast how Century stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Century Therapeutics more accurately as focusing exclusively on Century Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Century Therapeutics' intrinsic value based on its ongoing forecasts of Century Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Century Therapeutics' closest peers. If more than one evaluation category is relevant for Century Therapeutics we suggest using both methods to arrive at a better estimate.
Century Therapeutics Cash |
|
Century Valuation Trend
Comparing Century Therapeutics' enterprise value against its market capitalization is a good way to estimate the value of Century Therapeutics uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Century Therapeutics Total Value Analysis
Century Therapeutics is currently projected to have valuation of (88.27 M) with market capitalization of 47.75 M, debt of 48.96 M, and cash on hands of 378.76 M. The negative valuation of Century Therapeutics may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Century Therapeutics fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(88.27 M) | 47.75 M | 48.96 M | 378.76 M |
Century Therapeutics Investor Information
About 28.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.3. Some equities with similar Price to Book (P/B) outperform the market in the long run. Century Therapeutics has Price/Earnings To Growth (PEG) ratio of 0.26. The entity recorded a loss per share of 1.61. The firm had not issued any dividends in recent years. Based on the key indicators related to Century Therapeutics' liquidity, profitability, solvency, and operating efficiency, Century Therapeutics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Century Therapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Century Therapeutics has an asset utilization ratio of 1.87 percent. This indicates that the Company is making $0.0187 for each dollar of assets. An increasing asset utilization means that Century Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Century Therapeutics Ownership Allocation
Century Therapeutics holds a total of 86.05 Million outstanding shares. Over half of Century Therapeutics' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Century Therapeutics Profitability Analysis
The company reported the previous year's revenue of 6.59 M. Net Loss for the year was (126.57 M) with loss before overhead, payroll, taxes, and interest of (100.66 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Century Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Century Therapeutics and how it compares across the competition.
About Century Therapeutics Valuation
The stock valuation mechanism determines Century Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Century Therapeutics. We calculate exposure to Century Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Century Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 6.6 M | 4.9 M | |
| Pretax Profit Margin | (18.94) | (19.88) | |
| Operating Profit Margin | (20.96) | (22.01) | |
| Net Loss | (19.21) | (20.17) | |
| Gross Profit Margin | (5.56) | (5.84) |
Century Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 78.6 M |
Century Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Century Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Century we look at many different elements of the entity such as Century's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Century Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Century Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Century Therapeutics' worth.Complementary Tools for Century Stock analysis
When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |